SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 5(D) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported) April 23, 2002
E. I. du Pont de Nemours and Company
(Exact Name of Registrant as Specified in Its Charter)
Delaware |
1-815 |
51-0014090 |
(State or Other Jurisdiction |
(Commission |
(I.R.S. Employer |
Of Incorporation) |
File Number) |
Identification No.) |
1007 Market Street
Wilmington, Delaware 19898
(Address of principal executive offices)
Registrant's telephone number, including area code: (302) 774-1000
1
Item 5. Other Events
The Registrant Files, pursuant to Regulation FD, its earnings news release dated April 23, 2002, entitled "DuPont Reports First Quarter 2002 Earnings," a copy of which is below. This earnings news release is also filed in connection with Debt and/or Equity Securities that may be offered on a delayed or continuous basis under Registration Statements on Form S-3 (No. 33-53327, No. 33-61339, No. 33-60069 and No. 333-86363).
April 23, 2002 |
Contact: |
Clif Webb |
WILMINGTON, Del. |
302-774-4005 |
|
r-clifton.webb@usa.dupont.com |
DUPONT REPORTS FIRST QUARTER 2002 EARNINGS
Summary
Earnings Comparisons
($ per share diluted)
1Q'02 |
1Q'01 |
|
Underlying |
.55 |
.54 |
One-Time Items |
(.07) |
(.07) |
Reported |
.48 |
.47 |
2
"It is clear that the actions we took last year are beginning to pay off. We have removed costs from our company, focused on businesses where we can win, and increased our competitiveness in a way that is real and sustainable," said Charles O. Holliday, Jr., DuPont chairman and chief executive officer. "During the first quarter, we also embarked on the next major step to increase shareholder value. We are aggressively targeting growth by aligning our businesses in five market- and technology-based platforms, while creating a Textiles and Interiors subsidiary that will be separated from the company by year-end 2003. Our leadership and employees are focused and determined to meet these goals."
Global Sales and Income
For the quarter, consolidated sales totaled $6.1 billion compared to $6.9 billion in 2001. Segment sales, including transfers and a pro rata share of sales by equity affiliates, were $6.8 billion, down 11 percent from $7.6 billion in 2001. Net income before one-time items was $552 million versus $567 million in 2001, resulting in earnings per share of $.55 compared to $.54 last year. Average outstanding shares decreased 4 percent. Underlying earnings reflect higher Agriculture & Nutrition and Pharmaceuticals segment results offset by reduced earnings across the company's other segments. Excluding Agriculture & Nutrition and Pharmaceuticals, results versus prior year principally reflect lower local selling prices, a stronger U.S. dollar and weaker volumes, partly offset by lower raw material costs. Improved Agriculture & Nutrition results reflect in part a benefit from the absence of goodwill amortization as the result of new accounting rules adopted in 2002.
Net income including one-time items was $479 million, compared to $495 million in the first quarter of 2001, resulting in earnings per share of $.48 compared to $.47 last year. One-time items are described in the notes to the accompanying financial statements and are summarized in the table below:
3
ONE-TIME ITEMS
$MM Pretax |
$MM After-Tax |
($ Per Share) |
||||
2002 |
2001 |
2002 |
2001 |
2002 |
2001 |
|
Argentina - Dollar to Peso Conversion |
(63) |
(63) |
(.06) |
|||
Withdrawal from DTI Polyester JV |
(39) |
(29) |
(.03) |
|||
Litigation Settlement - DTI Nylon JV |
30 |
19 |
.02 |
|||
Adoption of SFAS 133* |
19 |
11 |
.01 |
|||
Purchase Accounting - Pioneer |
(133) |
(83) |
(.08) |
|||
1st Quarter - Total |
(72) |
(114) |
(73) |
(72) |
(.07) |
(.07) |
* |
Reflects the cumulative effect of a change in accounting principle. Effective January 1, 2001, the company adopted SFAS 133 - "Accounting for Derivative Instruments and Hedging Activities," as amended. |
Segment Sales
Regional segment sales and related variances for the first quarter 2002 compared with the first quarter 2001 are summarized below:
Segment Sales |
% Change Due To |
|||||
|
1Q'02 $B |
% Change vs. 1Q'01 |
Local Price |
Currency Effect |
Volume |
Acquisition/ Divestiture* |
Worldwide |
6.8 |
(11) |
(4) |
(2) |
(2) |
(3) |
U.S. |
3.4 |
(11) |
(4) |
0 |
(2) |
(5) |
Europe |
1.8 |
(14) |
(4) |
(4) |
(2) |
(4) |
Asia Pacific |
1.0 |
(12) |
(5) |
(4) |
(2) |
(1) |
Canada, Mexico, South America |
0.6 |
(10) |
(3) |
(2) |
(2) |
(3) |
* |
Includes impact of the sale of Pharmaceuticals and selected polyester businesses and withdrawal from the BenlateÒ fungicide business. |
Business Segment Performance
Summarized below are comments on individual segment results excluding one-time items for the first quarter 2002 compared to first quarter 2001:
4
Second Quarter Outlook
DuPont expects business conditions in the United States and possibly in Europe to continue to improve, bringing sequential volume increases in the second quarter to most of its businesses. The company has not changed its view that a significant period of demand growth is needed to absorb capacity before pricing strengthens in the manufacturing sector.
Therefore, the company expects sequential volume momentum and year-over-year lower raw materials costs to benefit results. These positives will likely be mitigated by a continued strong dollar and difficult price environment.
5
Taking all of these factors into account, the company anticipates second quarter underlying earnings per share to show double-digit improvement versus the prior year and to be about equal to first quarter 2002 underlying earnings per share of $0.55.
"We have placed our emphasis on growth in large markets with unmet needs where customers have a willingness to reward our strengths - creative solutions based on scientific know-how and innovation," said Holliday. "Across the company, our people are committed to drive growth and improve productivity. We are on the right track."
Forward-Looking Statements: This news release contains forward-looking statements based on management's current expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the company's strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. Some of the forward-looking statements may be identified by words like "expects," "anticipates," "plans," "intends," "projects," "indicates," and similar expressions. These statements are not guarantees of future performance and involve a number of risks, uncertainties and assumptions. Many factors, including those discussed more fully elsewhere in this release and in documents filed with the Securities and Exchange Commission by DuPont, particularly its latest annual report on Form 10-K and quarterly report on Form 10-Q, as well as others, could cause results to differ materially from those stated. These factors include, but are not limited to changes in the laws, regulations, policies and economic conditions, including inflation, interest and foreign currency exchange rates, of countries in which the company does business; competitive pressures; successful integration of structural changes, including restructuring plans, acquisitions, divestitures and alliances; cost of raw materials, research and development of new products, including regulatory approval and market acceptance; and seasonality of sales of agricultural products.
# # #
4/23/02
6
E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES
Three Months Ended |
||||||||
CONSOLIDATED INCOME STATEMENT |
March 31 |
|||||||
(Dollars in millions, except per share) |
2002 |
2001 |
||||||
SALES |
$6,142 |
$6,859 |
||||||
Other Income(a) |
57 |
170 |
||||||
Total |
6,199 |
7,029 |
||||||
|
||||||||
Cost of Goods Sold and Other Operating Charges(b) |
3,984 |
4,486 |
||||||
Selling, General and Administrative Expenses |
645 |
757 |
||||||
Depreciation |
305 |
327 |
||||||
Amortization of Goodwill and Other Intangible Assets(c) |
51 |
112 |
||||||
Research and Development Expense |
287 |
410 |
||||||
Interest Expense |
90 |
178 |
||||||
Employee Separation Costs and Write-Down of Assets(d) |
9 |
- |
||||||
Total |
5,371 |
6,270 |
||||||
INCOME BEFORE INCOME TAXES AND MINORITY INTERESTS |
828 |
759 |
||||||
Provision for Income Taxes |
328 |
272 |
||||||
Minority Interests in Earnings of Consolidated Subsidiaries |
21 |
3 |
||||||
INCOME BEFORE CUMULATIVE EFFECT OF A CHANGE IN ACCOUNTING PRINCIPLE |
479 |
484 |
|
|
|
|||
Cumulative Effect of a Change in Accounting Principle, Net of Income Taxes(e) |
- |
|
11 |
|
|
|||
NET INCOME |
$ 479 |
$ 495 |
||||||
BASIC EARNINGS PER SHARE OF COMMON STOCK(f) |
||||||||
Income before Cumulative Effect of a Change in Accounting Principle |
$ .48 |
$ .46 |
|
|||||
Cumulative Effect of a Change in Accounting Principle |
- |
.01 |
||||||
Net Income |
$ .48 |
$ .47 |
||||||
DILUTED EARNINGS PER SHARE OF COMMON STOCK(f) |
||||||||
Income before Cumulative Effect of a Change in Accounting Principle |
$ .48 |
$ .46 |
|
|||||
Cumulative Effect of a Change in Accounting Principle |
- |
.01 |
||||||
Net Income |
$ .48 |
$ .47 |
||||||
DIVIDENDS PER SHARE OF COMMON STOCK |
$ .35 |
$ .35 |
7
FOOTNOTES TO CONSOLIDATED INCOME STATEMENT
Under the new standard, the Company must measure by the end of 2002 the amount, if any, of goodwill impairment. The Company currently expects to complete the necessary tests and finalize the amount of any impairment charges by no later than the end of the third quarter 2002. Based on work to-date, preliminary indications are that a potential impairment exists in two reporting units (Pioneer Hi-Bred International Inc., and DuPont Flooring Systems Inc.). The recorded goodwill in these units totals $2,900 at December 31, 2001. First quarter 2002 results will be restated to include a "Change in Accounting Principle" adjustment for any goodwill impairment charges as required by SFAS No. 142.
and Hedging Activities," as amended.
(f) Earnings per share are calculated on the basis of the following average number of common shares outstanding:
Three Months Ended |
||
March 31 |
||
|
Basic |
Diluted |
|
||
2002 |
995,776,462 |
1,001,260,784 |
2001 |
1,042,168,259 |
1,047,973,561 |
8
E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES
Three Months Ended |
|||||||
CONSOLIDATED SEGMENT INFORMATION(a) |
March 31 |
||||||
(Dollars in millions) |
2002 |
2001 |
|||||
SEGMENT SALES (b) |
|||||||
Agriculture & Nutrition |
$1,587 |
$1,520 |
|||||
Coatings & Color Technologies |
1,137 |
1,205 |
|||||
Electronic & Communication Technologies |
578 |
784 |
|||||
Performance Materials |
1,152 |
1,207 |
|||||
Pharmaceuticals |
- |
205 |
|||||
Safety & Protection |
828 |
965 |
|||||
Textiles & Interiors |
1,450 |
1,697 |
|||||
Other |
26 |
52 |
|||||
Total Segment Sales |
6,758 |
7,635 |
|||||
Elimination of Transfers |
(95) |
(146) |
|||||
Elimination of Equity Affiliate Sales |
(523) |
(628) |
|||||
Miscellaneous |
2 |
(2) |
|||||
CONSOLIDATED SALES |
$6,142 |
$6,859 |
|||||
|
|||||||
AFTER-TAX OPERATING INCOME (LOSS) |
|||||||
Agriculture & Nutrition(c) |
$ 323 |
$ 172 |
|||||
Coatings & Color Technologies |
85 |
140 |
|||||
Electronic & Communication Technologies |
45 |
115 |
|||||
Performance Materials |
85 |
95 |
|||||
Pharmaceuticals |
51 |
(64) |
|||||
Safety & Protection |
103 |
132 |
|||||
Textiles & Interiors(d) |
19 |
64 |
|||||
Other |
(20) |
(3) |
|||||
Total Segment ATOI |
691 |
651 |
|||||
Interest & Exchange Gains and Losses(e) |
(122) |
(97) |
|||||
Corporate Expenses |
(78) |
(70) |
|||||
Corporate Minority Interest(f) |
(12) |
- |
|||||
Income from Operations |
479 |
484 |
|||||
Cumulative Effect of a Change in Accounting Principle |
- |
11 |
|||||
NET INCOME |
$ 479 |
$ 495 |
9
FOOTNOTES TO CONSOLIDATED SEGMENT INFORMATION
(a) Segment data for 2001 has been reclassified to reflect the Company's realignment of its businesses into five market- and technology-focused growth platforms, and the formation of a Textiles & Interiors subsidiary. The Company retained its Pharmaceuticals segment.
10
E. I. DUPONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES
SEGMENT SALES(a)
(1st QUARTER 2002 VS. 1st QUARTER 2001)
Segment Sales |
|||||||||
Three Months Ended |
Percentage Change Due to: |
||||||||
March 31 |
U.S.$ |
||||||||
$ |
% Change |
Price |
Volume |
Other(b) |
|||||
Agriculture & Nutrition |
$1,587 |
4% |
- |
4% |
|
||||
Coatings & Color Technologies |
1,137 |
(6) |
(7)% |
1 |
|||||
Electronic & Communication Technologies |
578 |
(26) |
(13) |
(13) |
|||||
Performance Materials |
1,152 |
(5) |
(7) |
2 |
|||||
Pharmaceuticals |
- |
(100) |
- |
- |
(100)% |
||||
Safety & Protection |
828 |
(14) |
(1) |
(13) |
|
||||
Textiles & Interiors |
1,450 |
(15) |
(11) |
- |
(4) |
||||
Other |
26 |
(50) |
- |
(15) |
(35) |
||||
Total |
$6,758 |
|
(11)% |
(6)% |
(2)% |
(3)% |
(a) |
Includes transfers and pro rata share of equity affiliate sales. |
(b) |
Reflects sales decrease due to pharmaceuticals divestiture, divestiture of certain polyester businesses, |
And withdrawal from BenlateÒ fungicide. |
SEGMENT INFORMATION |
Three Months Ended |
|||||||||||
EXCLUDING IMPACT OF ONE-TIME ITEMS - |
March 31 |
|||||||||||
(Dollars in millions) |
2002 |
2001 |
% Chg. |
|||||||||
AFTER-TAX OPERATING INCOME (LOSS) |
||||||||||||
Agriculture & Nutrition |
$ 323 |
$ 255 |
|
27% |
||||||||
Coatings & Color Technologies |
85 |
140 |
|
(39) |
||||||||
Electronic & Communication Technologies |
45 |
115 |
(61) |
|||||||||
Performance Materials |
85 |
95 |
(11) |
|||||||||
Pharmaceuticals |
51 |
(64) |
N/M |
|||||||||
Safety & Protection |
103 |
132 |
(22) |
|||||||||
Textiles & Interiors |
29 |
64 |
(55) |
|
||||||||
Other |
(20) |
(3) |
N/M |
|
||||||||
Total Segment ATOI |
701 |
734 |
(4) |
|||||||||
Interest & Exchange Gains and Losses |
(59) |
(97) |
||||||||||
Corporate Expenses |
(78) |
(70) |
||||||||||
Corporate Minority Interest |
(12) |
- |
||||||||||
INCOME FROM OPERATIONS |
$ 552 |
$ 567 |
(3)% |
11
E. I. DUPONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES
FINANCIAL SUMMARY
(Dollars in millions, except per share)
Three Months Ended |
|||||||||||
March 31 |
|||||||||||
2002 |
2001 |
% Chg. |
|||||||||
Selected Income Statement Data - |
|||||||||||
Excluding Impact of One-Time Items |
|||||||||||
And Cumulative Effect of a Change |
|||||||||||
In Accounting Principle |
|||||||||||
Consolidated Sales |
$6,142 |
$6,859 |
(10)% |
|
|||||||
Segment Sales |
6,758 |
7,635 |
(11) |
||||||||
Segment ATOI |
701 |
734 |
(4) |
||||||||
EBIT |
1,005 |
1,086 |
(7) |
||||||||
EBITDA |
1,361 |
1,525 |
(11) |
||||||||
Income from Operations |
552 |
567 |
(3) |
||||||||
EPS - Diluted |
0.55 |
0.54 |
2 |
||||||||
|
||||||
1st Quarter 2002 Vs. |
||||||
1st Quarter 2001 |
||||||
|
||||||
Segment ATOI Variance Analysis - |
||||||
Excluding Impact of One-Time Items |
||||||
Local Prices |
$(195) |
|||||
Volume |
(35) |
|||||
Costs |
75 |
|||||
Currency |
(20) |
|||||
Other (Primarily Pharmaceuticals) |
142 |
|||||
Total |
$ (33) |
12
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
E. I. DU PONT DE NEMOURS AND COMPANY |
(Registrant) |
/s/ D. B. Smith |
D. B. Smith |
Assistant Controller |
April 23, 2002
13